Click here for Teams Link:

Objectives

  • Describe the role of food allergy testing in eosinophilic esophagitis management.
  • Discuss how to implement elimination diet into treatment of eosinophilic esophagitis treatment.
  • List the signs and symptoms of eosinophilic esophagitis.
  • Define the treatment and management of eosinophilic esophagitis.

 

PDF icon “To view additional information on the Nemours Children’s disclosure policy, right click on this link to open in a new window.”

This Microsoft Teams service includes a feature that allows audio and any documents and other materials exchanged or viewed during the session to be recorded. By joining this session, you automatically consent to such recordings. If you do not consent to the recording, discuss your concerns with the meeting host prior to the start of the recording or do not join the session. Please note that any such recordings may be subject to discovery in the event of litigation.

Session date: 
08/21/2024 - 8:00am to 9:00am EDT
Location: 
Add to calendar: 
  • 1.00 MOC ABP - Pediatrics
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.00 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.
  • 1.00 MOC ABS – Surgery
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

Please login or register to take this course.
Faculty List: 
Speaker(s)

Sean Gallagher

has no relevant financial relationships to disclose at this time.

Erica Lardieri, DO

has no relevant financial relationships to disclose at this time.